Cellectar Biosciences, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Cellectar Biosciences, Inc. (CLRB) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 82.00% for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2015-11-12
- Cellectar Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 0.87%, a 66.92% decline year-over-year.
- Cellectar Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 2.63%.
- Cellectar Biosciences, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2014 was 1.07%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2015-09-30 | 82.00% 10-Q · filed 2015-11-12 | |||
| 2015-06-30 | 0.88% 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | 0.87% 10-Q · filed 2015-05-20 | |||
| 2014-12-31 | 1.07% 10-K · filed 2015-05-20 | |||
| 2014-09-30 | 1.07% 10-Q · filed 2015-05-20 | |||
| 2014-06-30 | 1.76% 10-Q · filed 2014-08-04 | |||
| 2014-03-31 | 2.63% 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | 0.92% 10-Q · filed 2015-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |